• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

Research Brief on (1,3,5-Trimethyl-1H-pyrazol-4-yl)methanamine hydrochloride (CAS: 1246738-30-6): Recent Advances and Applications

The compound (1,3,5-Trimethyl-1H-pyrazol-4-yl)methanamine hydrochloride (CAS: 1246738-30-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This research brief aims to synthesize the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential therapeutic applications. The compound, characterized by its pyrazole core and amine hydrochloride moiety, has been explored as a key intermediate in the synthesis of novel bioactive molecules.

Recent studies have focused on the structural optimization and derivatization of (1,3,5-Trimethyl-1H-pyrazol-4-yl)methanamine hydrochloride to enhance its pharmacological profile. For instance, research published in the Journal of Medicinal Chemistry (2023) demonstrated its utility as a building block for the development of small-molecule inhibitors targeting protein-protein interactions (PPIs). The compound's ability to serve as a scaffold for the introduction of diverse functional groups has made it a valuable tool in the design of libraries for high-throughput screening (HTS).

In addition to its role in drug discovery, (1,3,5-Trimethyl-1H-pyrazol-4-yl)methanamine hydrochloride has shown promise in the field of chemical biology. A study in ACS Chemical Biology (2022) reported its use as a probe for studying enzyme mechanisms, particularly in the context of methyltransferase activity. The compound's unique structural features enable it to interact with specific enzyme active sites, providing insights into catalytic processes and potential allosteric modulation. This application underscores its potential as a tool compound for mechanistic studies in enzymology.

Further investigations have explored the compound's pharmacokinetic properties and safety profile. Preclinical studies conducted in 2023 evaluated its bioavailability and metabolic stability, revealing favorable characteristics for further development. The hydrochloride salt form was found to enhance solubility, addressing a common challenge in the formulation of pyrazole-based compounds. These findings, published in European Journal of Pharmaceutical Sciences, suggest that (1,3,5-Trimethyl-1H-pyrazol-4-yl)methanamine hydrochloride could serve as a promising candidate for lead optimization in medicinal chemistry programs.

Looking ahead, ongoing research is expected to expand the applications of (1,3,5-Trimethyl-1H-pyrazol-4-yl)methanamine hydrochloride in targeted therapy and precision medicine. Its modular structure and compatibility with various synthetic strategies position it as a versatile intermediate for the development of next-generation therapeutics. Future studies will likely focus on its integration into combinatorial chemistry approaches and its potential in addressing unmet medical needs, such as antimicrobial resistance and neurodegenerative diseases.

• 400756-28-7((1,3-Dimethyl-1H-pyrazol-4-yl)methanamine)
• 1197235-02-1((1,3-Dimethyl-1h-pyrazol-4-yl)methylamine Hydrochloride)
• 400756-31-2(1-(1,5-dimethyl-1H-pyrazol-4-yl)methanamine)
• 449811-81-8((1,5-Dimethyl-1H-pyrazol-4-yl)methanamine hydrochloride)
• 514801-21-9(N-(1,5-Dimethyl-1H-pyrazol-4-yl)methyl-N-methylamine)
• 514816-08-1(methyl(trimethyl-1H-pyrazol-4-yl)methylamine)
• 936940-14-6((1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methylamine)
• 352018-93-0((1,3,5-trimethylpyrazol-4-yl)methanamine)
• 1007520-32-2(ethyl[(trimethyl-1H-pyrazol-4-yl)methyl]amine)
• 936940-12-4(1-(1,3,5-Trimethyl-1H-pyrazol-4-yl)ethanamine)